News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

digiMedical Solutions, Inc.™ (DGMS) Announces Sales Channel Agreement With 1,500 Offices Nationwide


6/15/2009 10:42:22 AM

COLLEYVILLE, TX--(Marketwire - June 15, 2009) - digiMedical Solutions, Inc.™ (PINKSHEETS: DGMS), today released a letter to shareholders from Company CEO David Lee. The letter provides an operational update on the Company's proprietary digital prescription software suite and increased sales channels. The letter is included in its entirety below.

Separately, the Company recently launched a new interactive digital prescription website allowing doctors and pharmacists to sign up online to use digiMedical's products. The new site, www.digiReAuth.com, is part of an ongoing effort by the Company to market digiRX, a thin client suite of products providing digital prescription and reauthorization services to doctors, pharmacists and patients. Utilizing the latest Microsoft technologies such as .NET, AJAX and Microsoft SQL, the Company has developed a suite of products to digitally manage the prescription process. The Company's products comply with all HIPAA and DEA requirements for patient medical record security.

Dear Fellow Shareholders,

In my shareholder letter released March 24th of this year, I outlined what directions digiMedical would be undertaking for 2009. Let me recap these directions for you and give you an update as to our progress.

Quarter One Activity

In recent months, the Company announced that it is growing its advisory board, with the most recent addition being Jason Whisenant, www.digiMedical.com/News/News.aspx. He and others like him will help expand the Company's ability to forecast future trends and marketing segments in the digital prescription industry, while at the same time improving our sales and marketing division.

Over the course of the first quarter, the Company also launched our new corporate website www.digiMedical.com, detailing our proprietary digital prescription software. We also launched two other vital websites www.digiRX.com and www.digiReAuth.com. These websites allow doctors and pharmacists to find out about our products and services and sign up via the Web. These websites leverage our software and significantly expand our ability to sell to and service the market with minimal backend manpower, resulting in a strong platform allowing for exponential sales growth.

Quarter Two Activity

Board member Philip Verges, CEO of NewMarket Technology (PINKSHEETS: NMKT), introduced VirtualHealth (OTCBB: VHGI) and our Company. VirtualHealth has a medical practice management system software product with a large client base (for more information visit http://www.mosonline.com). I am pleased to announce a new, signed contract with VirtualHealth to offer our software and services in conjunction with their software to their client base of over 1,500 offices nationwide.

This is a significant move for digiMedical to increase our sales channels and our software's visibility in the market. In the third quarter, we will contiue to work on this new sales channel to sign on more doctors. We plan to issue more information on this agreement in the future and we will continue to look for other large sales channels to partner with.

Additionally, in quarter three, we are planning to roll out a new version, 3.0, of our digiRX product.

Summary

digiMedical is focused on expanding our market share through reselling our software products digiRX, digiReAuth and digiPRN Pharmacies by forging agreements with partners that have an existing client base and sales channels, like with VirtualHealth, that will significanlty increase our sales and visibility in the market.

We recognize this is a difficult economy, and therefore perhaps a difficult time to be a development stage company. However, we are enthusiastic about our progress to date and consider our recent channel agreement, in conjunction with our already proven, in production software to be a significant milestone for the Company. I hope shareholders share our enthusiasm and if so, I would ask you spread the word. Everyone knows at least one doctor, so let them know about our products. We are proud of the products we have developed and the security and savings they have brought our clients. digiMedical is a great story, and we have set the foundations for a bright future.

Thank you all for your patience and support.

Best regards,

David W. Lee

CEO of digiMedical Solutions, Inc.

To be added to digiMedical's corporate e-mail list to receive company updates, please send an e-mail to ir@digimedical.com.

About digiMedical Solutions, Inc.™ (www.digiMedical.com)

digiMedical Solutions, Inc.™ is a pharmacy and medical technology company focused on developing next generation, digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless based d-prescription technology to physicians, direct marketing of the company's digital call center services for refills and reauthorization and partnering with independent pharmacy chains to focus sales with the technology suite.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission.


Contact:
digiMedical Solutions, Inc.
Investor Relations
214-722-3029
ir@digimedical.com
www.digimedical.com


Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES